MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2023 International Congress

August 27-31, 2023. Copenhagen, Denmark.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • PSP registry: preliminary cross-sectional results of the first 2 years of recruitment of a multicenter registry and biorepository.

    C. Painous, M. Fernandez, M. Soto, A. Cámara, Y. Compta (Barcelona, Catalonia)

  • PSP-like phenotype triggered by STN DBS in PD: a case report

    W-H. Chang, Y-C. Chen, P-L. Chen, P-H. Tu, C-H. Yeh, T-C. Liu, C-S. Lu, C-C. Chen (Taoyuan, Taiwan)

  • Psychometric properties of the Neuropsychiatric Fluctuations Scale: preliminary results in patients with Parkinson’s disease

    C. Rodriguez-Blazquez, I. Debove, S. Murcia, A. Zenger, MM. Kurtis, E. Cubo, C. Falup-Pecurariu, KR. Chaudhuri, H. Reichmann, B. Falkenburger, S. Bostantjopoulou, P. Martinez-Martin, MJ. Forjaz, M. Bereau, P. Krack (Madrid, Spain)

  • Psychosocial factors impacting participation in a time-intensive deep brain stimulation study of individuals with Parkinson’s disease and dystonia

    A. Hahn, S. Cernera, C. Racine, S. Little, P. Starr (San Francisco, USA)

  • Publication rates and characteristics of clinical trials in deep brain and responsive neurostimulation

    M. Chua, A. Warren, J. Rolston (Boston, USA)

  • Pupil response is impaired in clinically isolated REM Sleep Behavior Disorder and Parkinsons’ Disease

    W. Hermann, M. Brandt, T. Sehr, U. Walter, H. Reichmann, A. Storch, T. Ziemssen (Rostock, Germany)

  • Putting the patient’s voice at the venter: Tracking the impact of botulinum neurotoxin therapy for movement disorders using patient-reported outcomes

    S. Samadzadeh, V. Koska, J. Waskönig, PJ. Jouvenal, SGM. Meuth, HH. Hefter, PA. Albrecht (Düsseldorf, Germany)

  • Quantification motor improvement from levodopa carbidopa infusion gel therapy in patients with Parkinson’s disease using a wearable device.

    JHR. Herreros-Rodriguez, AEL. Esquivel López (Madrid, Spain)

  • Quantification of Striatal and Extrastriatal Dopamine Transporters with [18F]PR04.MZ and [18F] PI- 2620 PET in Patients with Progressive Supranuclear Palsy.

    X. Pizarro, P. Salles, P. Chana, V. Kramer (santiago, Chile)

  • Quantifying the impact of sensory tricks on the overall severity of cervical dystonia

    A. Mahajan, D. Gonzalez, G. Stebbins, C. Comella (Chicago, USA)

  • « Previous Page
  • 1
  • …
  • 138
  • 139
  • 140
  • 141
  • 142
  • …
  • 186
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #22901 (not found)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley